Does genistein lower plasma lipids and homocysteine levels in postmenopausal women? A meta-analysis
Authors:
- 24 June 2016
- journal article
- research article
- Published by Taylor & Francis in Climacteric
- Vol. 19 (5) , 440-447
Abstract
To perform a meta-analysis examining the effects of genistein on homocysteine and lipid levels in postmenopausal women. We systematically searched the PubMed, MEDLINE, and Cochrane Library databases and the ClinicalTrials.gov website for studies. We performed a meta-analysis using weighted mean differences (WMD) and 95% confidence intervals in a random-effects model. We assessed between-study heterogeneity using the Cochran's Q and I(2) statistics. Eight randomized, controlled trials with a total of 476 subjects were included in the meta-analysis. Compared with placebos, genistein was effective in reducing plasma levels of homocysteine (WMD, -0.58 μmol/l; p = 0.001), and increasing high density lipoprotein (HDL) cholesterol levels (WMD, 4.9 mg/dl; p = 0.0002). Subgroup analyses revealed that genistein significantly decreased the levels of low density lipoprotein (LDL) cholesterol (WMD, -16.90 mg/dl; p = 0.01), total cholesterol (WMD, -15.83 mg/dl; p = 0.008), and triglycerides (WMD, -46.58 mg/dl; p = 0.03) in postmenopausal women with metabolic syndrome, but had no significant effects in those with no metabolic syndrome. Our meta-analysis demonstrates that genistein significantly reduces homocysteine levels and increases HDL cholesterol levels in postmenopausal women. Genistein also significantly decreases LDL cholesterol, total cholesterol and triglyceride levels in postmenopausal women with metabolic syndrome.Keywords
This publication has 46 references indexed in Scilit:
- Biomarkers of cardiovascular disease risk in womenMetabolism, 2015
- Homocysteine level and risk of different stroke types: A meta-analysis of prospective observational studiesNutrition, Metabolism and Cardiovascular Diseases, 2014
- Vascular Effects of Estrogenic Menopausal Hormone TherapyReviews on Recent Clinical Trials, 2012
- Menopause and the Metabolic SyndromeThe Study of Women's Health Across the NationArchives of internal medicine (1960), 2008
- Homocysteine, Coagulation, Platelet Function, and ThrombosisSeminars in Thrombosis and Hemostasis, 2000
- Increased plasma homocysteine after menopauseAtherosclerosis, 2000
- Plasma Homocysteine Levels and Mortality in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1997
- Plasma Homocysteine as a Risk Factor for Vascular DiseaseJAMA, 1997
- Influence of age and menopause on serum lipids and lipoproteins in healthy womenAtherosclerosis, 1993
- HIGH DENSITY LIPOPROTEIN CHOLESTEROL AS A PREDICTOR OF CARDIOVASCULAR DISEASE MORTALITY IN MEN AND WOMEN: THE FOLLOW-UP STUDY OF THE LIPID RESEARCH CLINICS PREVALENCE STUDYAmerican Journal of Epidemiology, 1990